Eli Lilly
Trade Eli Lilly 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About LLY
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies.
LLY Key Statistics
Stock Snapshot
The current Eli Lilly(LLY) stock price is $1,079.27, with a market capitalization of 1.02T. The stock trades at a price-to-earnings (P/E) ratio of 53.30 and offers a dividend yield of 55.7%.
As of 2025-12-30, Eli Lilly(LLY) stock has fluctuated between $1,072.07 and $1,082.00. The current price stands at $1,079.27, placing the stock +0.7% above today's low and -0.3% off the high.
Eli Lilly(LLY) shares are trading with a volume of 691.21K, against a daily average of 3.04M.
In the last year, Eli Lilly(LLY) shares hit a 52-week high of $1,111.99 and a 52-week low of $623.78.
In the last year, Eli Lilly(LLY) shares hit a 52-week high of $1,111.99 and a 52-week low of $623.78.
LLY News
New insider activity at Eli Lilly & Co ( (LLY) ) has taken place on December 29, 2025. Claim 70% Off TipRanks This Holiday Season Unlock hedge fund-level data a...
Other drugmakers seem to be too far behind to disrupt this duopoly, at least for now. The weight loss market has garnered plenty of headlines over the past two...
Why Eli Lilly Is the Unexpected Must-Buy Dividend Powerhouse to Own in 2026 Quick Read Eli Lilly ( LLY ) achieved 54% year-over-year revenue growth to $17.6B i...
Analyst ratings
80%
of 30 ratingsMore LLY News
Below is Validea's guru fundamental report for ELI LILLY AND CO (LLY). Of the 22 guru strategies we follow, LLY rates highest using our Twin Momentum Investor m...
Key Points This pharma player offers you safety and growth. The company is a leader in a market that may approach $100 billion by the end of the decade. 10 s...
(RTTNews) - ABL Bio Inc. (298380.KQ), a South Korean biotechnology company, on Friday said it has secured a total of $55 million in research and development fun...
CRISPR Therapeutics (CRSP) just gave investors a fresh update on zugo cel, its off the shelf CAR T therapy, highlighting strong early responses, clean safety si...
Rumors persist that U.S. pharmaceutical giant Eli Lilly (LLY) will split its stock in the New Year. Claim 70% Off TipRanks This Holiday Season LLY stock has b...
Rumors have circulated that French biotechnology company Abivax (ABVX) has been attracting interest from Eli Lilly (LLY), according to a report in the French-la...
U.S.-based Eli Lilly & Co. (LLY) and Danish drug maker Novo Nordisk (NVO) are vying to capture a large portion of India’s rapidly growing obesity drug market. L...